Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …

Abstract The European Collaborative on Personalized Early Detection and Prevention of
Breast Cancer (ENVISION) brings together several international research consortia working …

Background Receiver operating characteristic (ROC) curves are useful tools to evaluate
classifiers in biomedical and bioinformatics applications. However, conclusions are often …

Breast density is an independent risk factor for breast cancer. In digital mammography and
digital breast tomosynthesis, breast density is assessed visually using the four-category …

The dynamic contrast-enhanced MR imaging plays a crucial role in evaluating the
effectiveness of neoadjuvant chemotherapy (NAC) even since its early stage through the …

The degree of normal fibroglandular tissue that enhances on breast MRI, known as
background parenchymal enhancement (BPE), was initially described as an incidental …

Dynamic contrast-enhanced (DCE) MRI provides both morphological and functional
information regarding breast tumor response to neoadjuvant chemotherapy (NAC). The …

Background Background parenchymal enhancement (BPE) is a known risk factor for breast
cancer. However, studies on the association between BPE and second breast cancer risk …

Breast cancer diagnosis is inherently multimodal. To assess a patient's cancer status,
physicians integrate imaging findings with a variety of clinical risk factor data. Despite this …

Background Background parenchymal enhancement (BPE) at breast MRI has been
associated with increased breast cancer risk in several independent studies. However …